2.2 Ketogenic metabolic therapy intervention strategy The trained team member provided basic education on diet composition, food groups, and monitoring tools as part of diet initiation
Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity
In this review we will focus on the effects of metformin on the gut and how its action within the intestine and on the intestinal enterocytes can explain at least some of the glucose-lowering effects of metformin, the increase in lactate concentrations and GI side-effects of this commonly used drug
Reaction coordinate of a functional model of tyrosinase: spectroscopic and computational characterization
GLP-1s are most effective when part of a bigger picturewhat we call a metabolic reset
These consultations allow monitoring of: Glycaemic control through HbA1c measurements (usually every 36 months) Weight changes and body composition Tolerability and adverse effects , particularly gastrointestinal symptoms Blood pressure and heart rate Renal function tests NICE recommends (NG28) that GLP-1 therapy should be continued only if there is demonstrable benefittypically defined as an HbA1c reduction of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight at six months for diabetes indications
